Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Degarelix (Firmagon) Peptide
GnRH antagonist providing immediate testosterone suppression in prostate cancer.
What is Degarelix (Firmagon)?
Degarelix (Firmagon) is a gnrh antagonist · hormonal peptide studied for advanced prostate cancer. Below is an educational overview of Degarelix (Firmagon) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Firmagon
Advanced prostate cancer.
A GnRH blocker that quickly lowers testosterone without the early hormone flare seen with older drugs like leuprolide.
- •Hot flashes
- •Injection-site reactions (often painful nodules)
- •Weight gain
- •Fatigue
- •Elevated liver enzymes
- •QT prolongation
- •Severe injection-site reactions
- •Possible cardiovascular events
- •Known hypersensitivity to degarelix
- •Pre-existing long QT syndrome (caution)
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Degarelix (Firmagon) Mechanism of Action
Synthetic decapeptide GnRH receptor antagonist. Blocks GnRH receptors directly, producing rapid suppression of LH, FSH, and testosterone without the initial flare seen with agonists.
Degarelix (Firmagon) Research Areas & Benefits
Degarelix (Firmagon) Dosage & Common Research Protocols
240 mg SC loading, then 80 mg SC monthly.
Protocols summarized for educational reference from published research. Not dosing guidance.
Degarelix (Firmagon) Studies & Cited Research
Degarelix vs leuprolide CS21 trial
Faster testosterone suppression and no testosterone surge vs leuprolide.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Degarelix (Firmagon) Side Effects & Safety Considerations
- •FDA-approved.
- •Injection-site reactions common.
Common questions about Degarelix (Firmagon)
More Hormonal peptides · See all 14
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.